You are here: Industry Insights > Cannabidiol

News List

Medical C B D Oil Side Effects and Drug Interactions PharmaSources/Keith J. Myers
October 20, 2020
Cannabidiol (CBD) has gained immense popularity for its ability to deal with various health conditions such as anxiety, insomnia, and chronic pain.
Vectura to provide preclinical support for Incannex's inhaled brain injury treatment cphi-online
June 24, 2021
IHL-216A may make sports safer and reduce the morbidity and mortality rates of people suffering serious head traumas
EmpowerPharm certified to manufacture CBD products to prescription drug standards in Canadian first cphi-online
June 09, 2021
New $30 million manufacturing facility in Burlington, Ontario, will allow company to manage R&D in-house and scale production without reliance on third-party manufacturers
22 Benefits Of C B D Oil: Based On Academic Research Health Canal
October 15, 2020
The FDA recently recommended[1] the approval of Epidiolex, this recommendation by the FDA marked an official turn in the long-standing fight to legalize cannabis-derived medicines and products.
FDA sends two warnings to companies selling unapproved CBD products europeanpharmaceuticalreview
April 30, 2020
Two companies selling unapproved cannabidiol (CBD) products including for the treatment of opioid addiction, have been handed warning letters from the FDA.
NICE to work with GW Pharma on cannabidiol evaluation europeanpharmaceuticalreview
August 29, 2019
NICE and GW Pharma will work together to address the issues highlighted in its evaluation of cannabidiol for treating two types of epilepsy.
Could CBD Treat Opioid Addiction? drugs
May 22, 2019
Cannabidiol (CBD) has been receiving a lot of attention lately as a potential treatment for everything from epilepsy to anxiety.
Cannabidiol may help to reduce seizures in Lennox-Gastaut syndrome europeanpharmaceuticalreview
April 29, 2019
Treatment with a pharmaceutical formulation of cannabidiol alongside other anti-epilepsy treatments helped to reduce the number of drop seizures in people with Lennox-Gastaut syndrome…
Revive Therapeutics Applies To FDA For Orphan Drug Designation of Cannabidiol For Treatment Of Liver Transplantation pharmafocusasia
November 27, 2018
Revive Therapeutics Ltd., a specialty medical cannabis company, today announced that it has submitted an application to the U.S. Food and Drug Administration (“FDA”) seeking ...
Emerald Health Pharmaceuticals Initiates Phase I Clinical Study on its Oral Drug Candidate Derived from Cannabidiol pharmafocusasia
September 29, 2018
Emerald Health Pharmaceuticals Inc. (EHP), a company developing medicines based on cannabinoid science, today announced the initiation of enrollment of its Phase I clinical trial of EHP-101, an oral formulation of a patented, synthetic new chemical entity

Previous page 1 2 Next page